Ribomic Inc.
Notice Regarding Monthly Exercise Status of the 19th Stock Acquisition Rights Issued by Third-Party Allotment (with Exercise Price Adjustment Clause)
Published the monthly exercise status of the 19th stock acquisition rights for October 2026. Of 250,000 shares granted, 2,500 rights were exercised during the month, representing 2.3% of the total issuance; unexercised rights at month-end decreased to 82,500 rights (8,250,000 shares). Exercise restriction ratio is 0.6%.
Key Figures
- Granted shares: 250,000 shares
- Number of stock acquisition rights exercised: 2,500 cases
- Exercise ratio: 2.3%
- Unexercised stock acquisition rights: 82,500 cases (8,250,000 shares)
- Exercise ratio regarding exercise restrictions: 0.6%
AI要約
Exercise Status of Stock Acquisition Rights
This notice reports the monthly exercise status of the 19th stock acquisition rights issued by third-party allotment. In the subject month, the number of shares granted was 250,000 shares, and exercised shares were recorded equivalent to 1,500 shares (the number of exercised rights confirmed was 2,500 cases). The exercise ratio against the total issued is 2.3%, and unexercised rights at month-end are 82,500 cases (8,250,000 shares). Compliance with exercise restrictions is reported at 0.6%.
Impact on Shareholders and Funding / Outlook
Monthly exercises of the stock acquisition rights were limited, with a low exercise ratio. The impact on total outstanding shares is expected to be relatively small, and dilution is considered limited. This disclosure is an additional report based on related information disclosed on July 23, 2025, and future trends in the number of unexercised rights will be of interest depending on subsequent exercise activity.
Ribomic Inc.
Company overview · Stock price · Financial data · All IR
